NCT06910033 - Long-term Safety and Performance of CMF Porous Titanium Implants | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions

Craniofacial Defects

Interventions

DEVICE

Craniomaxillofacial (CMF) porous titanium implant

All patients were treated, between 2016 and 2023, with patient-specific CMF Porous Titanium Implants for facial and/or cranial reconstruction or restoration of bone defects.

Trial Locations (2)

Unknown

Rigshospitalet, Copenhagen

Hôpital Pitié-Salpêtrière, Paris